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Seroprevalence of brucellosis among animal handlers and analysis of 
risk factors 
1.Introduction 
Brucellosis is a re-emerging infectious disease, by Brucella spp 
and usually transmitted to humans from infected animals. It is a most 
important source of disease in humans and live stocks. The clinical 
manifestations in humans differs from an acute febrile illness to a 
chronic, low grade ill defined disease. In each year 5,00,000 new cases 
are reported  worldwide, but according to the WHO these numbers 
greatly underestimate the true incidence, because the clinical picture of 
human brucellosis is extremely variable and misdiagnosed by physicians. 
However, the actual incidence seems to be twenty five times higher than 
the reported incidence. Brucella is considered a biological weapon in the 
category B pathogen, inhalation of only a few organisms is sufficient to 
cause infection. 
1.1 History   
Since, the man started to domesticating the livestocks  brucellosis 
has emerged as a disease.1 The disease was characterized with fever 
which has remissions and intermissions. It was known by several names 
in relation with places where it was more common viz Malta, 
Mediterranean, Gibraltar and undulant fever. 2  
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In 1895, J.A. Marston have given a correct description of the 
disease and he named it as “Mediterranean” or “Gartnic remittent fever”. 
The cause of the disease was obscure until 1886. Sir David Bruce a 
British army Medical Officer in 1887 demonstrated a plenty of 
microorganism   from a spleen of military personals who had infected and  
died of Gibraltar fever. Bruce reproduced the disease in chimpanzees 
with the isolates, and named this organism as “ Micrococcus melitensis.”3  
In the year 1897, Huges
 
  named the fever as undulant fever. Bang 
isolated the bacilli from  a aborted products of animals and  named that 
Bacillus abortus. 
4
 On June 14, 1905, Zammit  isolated the bacilli from 
infected goat’s  urine and  milk . Zammit also developed an agglutination 
test to detect agglutinin in the milk. Further work rendered it evident that 
goat was the natural host of Micrococcus melitensis and that infection 
was communicated to man by consumption of raw milk.5  
Alice C. Evans (1918) of Washington D.C., drew attention to the 
similarity between Micrococcus melitensis and Bacillus abortus, the 
causative agent of  Malta fever and  infectious miscarriages in cattles.6 In 
1920, the generic name Brucella was proposed by Meyer and Shaw for 
this microorganisms in honour of Bruce.7  Subsequently a  3rd species, 
Brucella suis was identified as a cause of epizootic abortion of swine.  4 th 
species, Brucella canis was identified as the cause of abortion in beagles. 
Brucella ovis was identified as the causative agent of contagious 
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epididymitis of rams  and Brucella neotomae was isolated from desert 
wood rats. Out of these the most important species that infect human 
beings are B. melitensis, B. abortus, B. suis and B. canis.2  
1.2 Epidemiology 
   1.2.1 Global scenario  
Brucellosis continues to be of great health significance and 
economic importance in many countries. Countries like the Arabian Gulf, 
the Indian subcontinent, Mediterranean basin  and parts of Mexico as well 
as central and South America are especially endemic for human 
brucellosis. In endemic areas, the reported incidence of human brucellosis 
varies  from <0.01 to > 200 in one lakh population.1 The world burden of 
human brucellosis remains  to be > five lakh  infections per year.8  In 
1990, Egypt and many Arabian countries reported a incidence of > 90 
thousand cases of human brucellosis per year.9  Every year, in USA 100 - 
200 brucella cases are reported. The incidence and prevalence of 
brucellosis varies from country to country. In endemic areas only few 
cases are reported it reflects the  poor surveillance and under reporting.10  
1.2.2 Indian scenario  
In India, brucellosis is a major emerging veterinary and civic health 
concern. The existence of brucellosis was noted  in the 20th century itself  
from  then it has been reported from almost all states of India but the 
situation varies  greatly between states.11 India is an agricultural country 
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and more than 3/4 th of the population  resides in rural areas having close 
contact with wild  and domestic animals.  Thus, the Indian population 
stands at a significant risk of acquiring zoonotic diseases as well as 
brucellosis. On the other hand, the reports regarding the distribution of 
brucellosis are often incomplete. This may be due to the fact that  poor 
diagnostic services, decreased  awareness and no exchange of  data  
among health and veterinary authorities.1 
1.3 Agent 
B.melitensis, B.abortus, B.canis and B.suis are the causative agent 
of human brucellosis. The species level identification of the bacteria are 
essential because the severity of disease in humans is mainly dependent 
on the type and source of the infection. Human brucellosis commonly 
caused by B.melitensis and B. abortus among this B.melitensis produce 
severe disease. The other species in this genus also cause disease in 
humans.12 
1.4 Morphology 
Brucella are small gram negative coccobacilli. They are shorter and 
slender have straight axis. The length vary from 0.6 - 1.5μm and breadth 
is 0.5 - 0.7μm. They are arranged singly,  pairs, short chains or in small 
groups. 
2
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Brucella  are gram negative, weakly acid fast, non-motile and non-
sporing. Resists the decolourisation by acid and alkali and  used in  
staining of infected tissues. A modification of Ziehl Neelsen method may 
be used, though it is not absolutely specific for Brucella.
2
 
1.5 Genome 
Brucella genome has 2 circular chromosomes of 2.1 Mb and 1.5 
Mb except B.suis biovar 3, which contains one chromosome of 3.1 Mb. 
The replicons code  for  important metabolic and replicative functions.13 
Natural plasmids have not been detected in Brucella, although 
transformation has been effected by wide host range plasmids after 
conjugative transfer or electroporation.14 
1.6 Antigenic determinants  
The important antigens  of Brucella includes the 
lipopolysaccharide (LPS) complex and two related polysaccharides. 
There are at least two antigenic determinants A (abortus) and M 
(melitensis ) which have been identified as the O chain of the LPS 
complexes. Strains of  B. abortus,   B. melitensis and B. suis can be A, M 
or A and M antigen positive. S-LPS is the immune predominant  and is 
one of the important virulence marker.  Plenty of periplasmic, outer or 
inner, cytoplasmic  proteins are identified.1  
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1.7 Cultural Characteristics  
Brucella is one of the difficult organisms to cultivate. They are 
aerobic bacteria and fail to grow in strict anaerobic conditions. Br. 
abortus is capnophilic in nature. This should be incubated   an atmosphere 
of 5% to 10% CO
2 
at 35°C to 37°C and colonies usually appear within 4 
to 5 days, but cultures should be kept for one month before they are 
declared as negative. 2               
Brucella species are usually isolated from blood or bone marrow 
cultures during the acute illness. Eduardo Gotuzzo et al
15 
reported that 
culture from bone marrow yields better results than blood cultures. The 
prior use of antimicrobials will reduce the blood culture positivity but 
will not affect the bone marrow culture. We can isolate the organisms 
from samples like CSF, lymph, urine and liver of infected patients.  
The biphasic culture method by Castaneda is recommended for the 
culture of blood and other body fluids.
16 
Solid media recommended for 
isolation of Brucella are trypticase soy agar, serum dextrose agar, 
tryptose agar, Douglas agar and  Brucella agar. The aqueous phase 
consists of the same basal medium without agar. 
2
 
Brucella strains grow on chocolate agar, blood agar and Brucella 
agar or some infusion base agar. 5% heated horse or rabbit serum 
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enhances growth on all media. The optimum pH range is 6.6 to 7.4. 
Temperature range is 20°C-40°C optimum being 37°C.
2
 
On subculture to solid media the colonies appear after 4-5 days and 
are 0.5 to 1 mm in diameter, raised convex, circular, moist, translucent 
and easily emulsifiable. On further incubation they increase in size to 4-6 
mm 2 . 
In synthetic media,  Pantothenate and erythritol  improves the 
growth of brucella and tryptophan and cystine are highly toxic to Br. 
abortus
17
.  
1.8 Biochemical Reaction  
 Brucella produces catalase  and many species of Brucella are 
oxidase positive except Br. ovis and B. neotomae. Many species reduces 
nitrate and it is variable in B.ovis and B. suis biogroup. Almost all 
species, except B. ovis and some strains of B.melitensis and B. abortus 
hydrolyze urea rapidly. B. ovis may hydrolyze urea weakly or not    at 
all.2                                                                                                 
B. abortus produces moderate amount of H
2
S for 4-8 days except 
the Danish variety, which does not produce H2S. The American strains of 
B. suis and B. neotomae also produce H2S, while B. melitensis, B. canis 
and B. ovis do not produce H2S. Brucella are negative for MR, VP and do 
not produce Indole.
2
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The commonly used method to identify Brucella from humans is 
the dye inhibition test. Dilutions of basic fuchsin and thionin are put up. 
B. abortus should grow only on basic fuchsin, B. suis only on thionin and 
B. melitensis on both
2
. 
The CO2 requirement of freshly isolated B.abortus for growth helps 
in differentiating them. The use of monospecific sera against the species 
helps in differentiating them from each other.  
1.9 Susceptibility to Physical and Chemical Agents  
Brucella are destroyed by heat at 60°C in 10 minutes and by 1% 
phenol in 15 minutes. They are killed by pasteurization. They remain 
viable for 10 days in refrigerated milk, 30 days in ice cream, 120 days in 
butter and for varying period in cheese depending on its pH. They are 
sensitive to direct sunlight and acid and tend to die in butter milk.  
Brucella will survive in bovine feaces for four months, in uterine 
exudate for at least 200 days and in liquid manuer for upto 2 ½ years if 
the temperature is kept near 0°C. Formaldehyde is the most effective of 
the commonly available disinfectants. 2  
1.10 Susceptibility to antimicrobial agents  
Most Brucella strains are sensitive to gentamicin, kanamycin 
tobramycin, amikacin and streptomycin. In vitro they are insensitive to  
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β-lactam antibiotics except monolactum and clavalunate potentiated 
amoxicillin. Sensitivity to tetracyclines is almost universal. 2  
1.11 Pathogenesis 
Brucella enters into the  human tissue by various routes like  
abrasions in the skin, alimentary canal, respiratory route.18 At or near the 
site of entry the bacteria are likely to be engulfed by either mononuclear 
or polymorpho nuclear cells.  After their entry into the macrophages, they  
are transported into various organs of the body.  
Within the phagocytic cells, these organism resists  the phagosome, 
lysosome fusion and  undergo replication19. As a result of this, the 
infected cells are destroyed by the pathogen if the process is not checked 
by the immune system. 
1.12 Host immune response 
Infection with Brucella usually results in the induction of both 
humoral and T-cell mediated immune response.  
1.13 High risk groups 
Veterinarians, abattoir worker, cattle ranchers, dairy farmers, meat 
sellers, meat inspectors, shepherds, goatherds, hunters, lab workers, 
travellers and persons consuming raw dairy products are particularly at 
risk.  
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1.14 Transmission  
The mode of transmission and prevalence of brucellosis depend on 
many  factors like dietary practice, customs in the society, socioeconomic 
status, climate, animal husbandry practices and environmental sanitation. 
The species of Brucella  that are infective to humans and livestock 
reservoir includes, B. melitensis in  goat and sheep, B. abortus in cattle, 
B. suis in pigs, and B. canis in dogs. The major source for transmission of 
disease in general population is the consumption of unpasteurized milk 
and its products which contains high amount of organism1.  
Though animal muscles contain low bacterial load, eating of 
improperly cooked meat can leads to brucellosis. Handling of live 
cultures and travel to endemic area also increases the risk.1  
Recently other routes of transmission have been identified like, 
infection through breast milk,20 sexual transmission,21 blood transfusion,  
bone marrow transplantation, infection contracted by an obstetrician 
during the delivery of a transplacentally infected baby21 and accidental 
inoculation with animal vaccines B. abortus strain S19  and B. melitensis 
Rev-1. 
1.15 Clinical spectrum 
Human brucellosis is a systemic infection, presents with wide  
spectrum of clinical manifestations. It usually presents as a fever without 
any apparent focus of infection. But in few cases focal forms are seen 
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which might affects many organs and systems of the body with the 
skeletal forms being more common, cardiac and neurological forms being 
more severe. The case fatality rate may be up to 2% and usually results 
from endocarditis. 2  
                      The onset of the disease may be either acute or insidious. 
The infective dose is low. It has a incubation period of 10-21 days to 
several months. Acute brucellosis mostly presents as a undulant pattern of 
fever with profuse sweating, body pain, loss of appetite and weight loss 
and fatigue. Liver, spleen and lymphnodes become enlarged.22 
1.16 Complications  
Osteoarticular, alimentary canal and hematologic forms are the 
common complications but the  cardiac, neurologic forms are more 
severe but infrequent.45 
1.16.1 Skeletal complications 
   Although monoarticular septic arthritis occur, 30 to 40% of 
patients have reactive symmetrical polyarthritis involving the knee, hip, 
shoulder, sacroiliac and sternoclavicular joints. Cultures of synovial fluid 
are positive in about 50% of cases.
24
Brucella osteomyelitis is rare.
25 
Bursitis and tendinitis due to Brucella  have also been reported but is very 
rare.
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1.16.2 Gastrointestinal system 
Gastrointestinal manifestations of Brucella infection are generally 
mild and may include nausea, vomiting, constipation, acute abdominal 
pain and diarrhea. Hepatic and spleenic enlargement may be seen in 15-
20 % of cases and abscesses may develop in the liver and spleen. Mild 
jaundice is seen in few cases.
25
  
1.16.3 Haematologic complications 
The heamatologic manifestations of brucellosis include anemia. 
leucopenia, thrombocytopenia and clotting disorders.26 Granulomas are 
found in the bone marrow in up to 75% of cases, but they are small and 
indistinct.   
1.16.4 Cardiovascular system 
Cardiovascular complication  of Brucellosis include endocarditis, 
myocarditis, pericarditis, aortic root abscess, mycotic aneurysms, 
thrombophlebitis with pulmonary aneurysms and pulmonary embolism. 
Brucella endocarditis usually involve the valves. It is reported to be the 
most common cause in fatal cases of human brucellosis.25 
1.16.5 Central nervous system 
Neurobrucellosis is uncommon but serious and includes meningo 
encephalitis, multiple cerebral or cerebellar abscesses, ruptured mycotic 
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aneurysms, myelitis, GB syndrome, cranial nerve lesion, hemiplegia, 
sciatica, myositis and rhabdomyolysis.
25
   
1.16.6 Genito urinary system 
The genitourinary infections due to Brucella include epididymo-
orchitis, prostatitis, seminal vesiculitis, dysmenorrhoea, tubo-ovarian 
abscess, salpingitis, cervicitis and acute pyelonephritis. Brucella has been 
isolated from urine in up to 50% of cases of genitourinary Brucella 
infection.
25
  
1.16.7 Ocular Complication  
A variety of ocular complications have been reported in patients 
with brucellosis. Uveitis is generally a late manifestation consisting of 
chronic iridocyclitis, nummular keratitis, multifocal choroidits and optic 
neuritis25.  
1.16.8 Skin Manifestation  
Skin manifestation of Brucella are uncommon. They include 
maculopapular eruption, purpura and petechiae, multiple cutaneous and 
subcutaneous abscess, discharging sinuses, superficial trombophlebitis, 
erythema nodosum and pemphigus.
25
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1.16.8 Respiratory System  
Respiratory illness due to Brucella include sore throat, tonsillitis, 
dry cough, hilar and paratracheal lymphadenopathy, pneumonia, solitary 
or multiple pulmonary nodular lung abscesses and empyema.
25
 
1.17 Chronic Brucellosis  
Since the onset of symptoms of brucellosis  is insidious, not easy  
to differentiate  between acute and chronic form of the disease. Most 
patients with chronic brucellosis have persisting foci of infection, such as 
suppurative lesions in bone, liver or spleen. Some patients who have had 
brucellosis will continue to have symptoms like malaise, lassitude and 
depression in the absence of objective evidence of infection.
27
 
1.18 Laboratory diagnosis 
The clinical presentation of brucellosis  mimics some infectious 
and noninfectious conditions. So, the diagnosis of the disease is very 
difficult and frequently delayed or missed. Early diagnosis of the disease 
and inclusion of proper antimicrobial treatment is vital for patients, 
especially to prevent the development of complications and appearance of 
relapses.  
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1.18.1 Culture 
Definitive diagnosis of brucellosis is made when Brucella are 
recovered from blood, bone marrow, lymph nodes, cerebrospinal fluid, 
urine, pus from abscesses and rarely from sputum, breast milk, vaginal 
discharges and seminal fluids.  Failure to isolate the bacteria is a 
drawback of blood culture due to the fact  for isolation, the bacteria needs 
extended incubation period, special media, and frequent subcultures are 
due to the fastidious, slow growing nature of the bacteria. Though bone 
marrow cultures are said to be the gold standard one, but results have not 
been generally reproducible. In  acute stage of the disease blood culture 
has increased sensitivity. Inspite of this, this test is not done routinely in 
rural areas, where the disease is endemic.28 
1.18.2 Serology 
The limitations of a blood culture makes serology the most useful 
way to diagnose. Detection of antibodies directed against the S-LPS, 
internal cytosolic proteins are the important antigens which are used in 
the serological diagnosis of brucellosis.  IgM agglutinins start to appear in 
the blood after 7 days of  disease followed by IgG. This IgG agglutinins 
will persist for longer periods even after the disease has been cured.29 
Many serological tests have been used for the diagnosis of human 
brucellosis.The test that are presently available are standard tube 
agglutination test (STAT), Antihuman globulin test, Rose bengal plate 
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test (RBPT), complement fixation, Enzyme linked immunosorbent assay 
(ELISA) and Immuno fluorescent antibody assay. STAT, Coombs test, 
ELISA are the widely used method for the detection of Brucella 
agglutinins.29 
1.18.2.1 Antigen detection 
Antigen detection which is the suitable alternative to blood culture 
but this test have not been standardized yet.30 
1.18.2.2 Antibody detection 
a. Rose Bengal Plate Test (RBPT)  
This is a simple and rapid plate agglutination test and has a higher 
degree of sensitivity for the diagnosis brucellosis irrespective of the stage 
of disease. This high sensitivity, rapid and easy to perform makes the test 
ideal for screening the patients for human brucellosis.1  
b. Standard tube agglutination test (STAT) 
STAT is the accepted test for obtaining quantitative information 
about the immune response against specific brucellar antigens. This test 
estimates the quantity of agglutinating antibodies (IgG and IgM). When 
suitable clinical manifestations are present a presumptive diagnosis of 
brucellosis is made serologically as a titre of 1in 160 and above. Where in 
endemic areas, a titre of 1in 320 dilution makes this test more specific 
one.1                    
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Even though this test being the more standard one, it is time- 
consuming  hence, unsuitable as a primary test for laboratories with large 
specimen workloads.31 In some sera a blocking factor may interfere with 
agglutination at low serum dilutions (Prozone phenomenon) this may be 
due to the presence of IgA or other non-agglutinating antibody. Another 
drawback is, the diagnosis of brucellosis cannot be established on the 
antibody titer by these classic test alone, because healthy persons engaged 
with animal husbandry practices may show significant titers 
of Brucella agglutinins.32 The other disadvantage is cross reactions 
between Brucella and other  bacteria such as Vibrio cholerae, 
Pseudomonas maltophilia, Francisella tularensis, Yersinia enterocolitica 
and Escherichia coli O: 157.  This  reactions can result in false positives 
in the serologic tests for brucellosis. 2  
c. Mercaptoethanol (ME) agglutination test  
This test determines the nature of immunoglobulins responsible for 
the agglutination in the STAT. In STAT, agglutination may be due to 
IgG, IgM or both. 2-mercaptoethanol destroys the agglutinating activity 
of IgM and therefore agglutination in this test is indicative of IgG.  This 
2-ME dissolves the disulphide links of IgM pentamer, thus interfers with 
its agglutinating capacity while not affecting IgG antibodies.33 
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d. Microagglutination test (MAT) 
Microagglutination test is a simpler and more efficient test than 
STAT. It can be performed more rapidly and employs less serum and 
antigen. It has been found to be more sensitive and specific than STAT. 
Since the MAT is simpler to perform than STAT and can potentially be 
automated. 
34
 
e. Anti human globulin test (Coombs test) 
This test detects the incomplete antibodies. Nowadays, the Coombs 
test is rarely performed in routine clinical laboratories because the 
procedure is too complex, time consuming and labor intensive, requires 
skilled persons to perfom the test. 1 
f. Complement Fixation Test:  
This test is mainly used in the diagnosis of chronic brucellosis. 3
 
It 
detects the complement fixing antibodies. It is the IgG antibody in 
brucellosis, which readily fixes complement. IgG appears late in the 
disease and hence this test is more useful in diagnosing chronic 
brucellosis. 33 
g. Enzyme Linked ImmunoSorbent Assay (ELISA) 
ELISA which is a more sensitive and specific test with  increased 
performance than other conventional tests. It gives a profile of Brucella 
specific IgA, IgM and IgG agglutinins in case of acute and chronic 
brucellosis.35 
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ELISA gives high sensitivity and specificity when compared  to 
STAT. 31and it is used for the diagnosis of chronic and complicated cases. 
In endemic areas this test   has significant diagnostic advantage than other 
conventional methods.35 ELISA can be used to study the subclass of Ig, 
so that the role of each Ig in the different phases and evolutional forms of 
brucellosis can be ascertained.29 It detects the antibodies against many 
bacterial antigenic structure like  S-LPS or cytoplasmic protein 
antigens.36 Applying a combination of IgM and IgG ELISA testing could 
be of value for the definitive diagnosis of brucellosis in developing 
countries, where diagnostic capabilities for culture, including automated 
culture systems and Polymerase chain reaction are poor.31 
h. Immunocapture agglutination test 
The Immunocapture agglutination test has high sensitivity and 
specificity that detects the antibodies against especially for S-LPS. 37  
1.18.3 Genomic detection 
Molecular diagnosis by polymerase chain reaction (PCR)  has been 
used for confirmation and differentiation of Brucella. This   methods are 
very useful for follow up testing of unusual phenotypes. PCR is a very 
expensive test   and  not used routinely as a diagnostic method.1 
1.18.4 Newer rapid tests 
The latex agglutination test and lateral flow immunoassay are the 
newer tests available for the detection of  Brucella IgG and IgM. It is a 
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rapid and simple test with increased  specificity and sensitivity and is a  
ideal test can be used in remote area.38  
In this back ground, the present study was conducted to assess the 
seroprevalence of brucellosis among animal handlers and to analyse the 
risk factors   associated with this infection in  Tirunelveli  district of 
Tamil nadu.       
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2. AIMS AND OBJECTIVES 
 
1. To detect the seroprevalence of brucellosis among animal handlers in 
Tirunelveli district of Tamil nadu. 
2. To analyse the risk factors associated with the seropositivity of 
Brucella infection. 
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3. REVIEW OF LITERATURE 
             Brucellosis is one of the world’s major zoonotic disease. It has a 
variable trend in United states and the European countries but has a 
predominant presence in Asia and in developing countries. It is a 
unrestrained public health crisis in developing countries like India, here it 
is  a common but often a ignored disease and it is also a disease of 
considerable economic and social importance. The prevalence of human 
brucellosis is difficult to estimate since many times the disease has been 
misdiagnosed or undiagnosed because of their inapparent or protean 
manifestations. Nowadays a wide battery of serological tests are available  
for the diagnosis of human brucellosis.  
3.1 Prevalence 
3.1.1 Global prevalence 
Brucellosis is an important global problem. It is a reemerging 
zoonotic disease cause severe economic loss and infection to humans.  
Most of the developing countries the burden of the disease is increased by 
the absence of national surveillance programme and inadequate 
laboratory facilities. Some countries, conventionally considered to be 
endemic-e.g: Israel, France and most of Latin America but now  
controlled the brucellosis.1  But, in central Asia  the new foci of infection 
been emerged. The  circumstances  in  Syria  has  been  fast  declining.   
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In Arabian countries, the prevalence  of  human brucellosis  is higher as a 
result of  increased live stock production units.      
In 1999, Mohammed A Al Sekait 39 done a seroepidemiological 
survey in Saudi Arabia  and the results revealed that the seroprevalence 
was 15.0%. Seropositivity of brucellosis from various regions of 
Mediterranean basin varied  from 8% in Jordan 40 to 12% in Lebanon and 
Kuwait.41,42  Even higher seroprevalence rates have been reported in Sub-
Saharan countries, with 18% in Uganda 43 and 13% in Nigeria.        
A Seroepidemiological study  conducted in Kars district of Turkey 
for period of 2 years from Jan- 2004 to Dec-2006 revealed  that the 
seroprevalence was 17.88%. 44 In a study conducted by Apan et al 2007 45 
in Middle Anatolia, Turkey, the seroprevalence of brucellosis was 
determined as 3.2%. 
Kose et al in 2006 46  reported  the seroprevalence of 2.9 to 8.5%  
in rural and suburban communities in West Anatolia, Turkey. Another 
study performed in Middle Anatolia by Cetinkaya et al 2005 47 revealed 
that the  seropositivity was 4.8%.  
A Serological survey conducted by Cadmus S.I.B et al 2004 48 
showed that the overall seroprevalence of brucellosis in Ibadan , 
Southwestern Nigeria was 31.82%. 
Hajia et al 49 had done a study to estimate the antibody levels of 
Brucellosis and showed the prevalence rate to be 3.28% in Hamedan, 
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Western Iran. Bokaei et al 50 studied the prevalence rate of brucellosis in 
Birjand, Iran. It was 37 in one lakh  population 
A study conducted on the seroprevalence of brucellosis in 184 
suspected cases 51 for period of 2004 to 2009 showed that 5.4% were 
seropositive for Brucella agglutinins in their serum. 
A study  done  in  Pyrexia of Unknown Origin  patients of Makurdi 
in 2004 52  revealed that among a  total of 1040  serum samples  screened, 
the overall seroprevalence was 7.6%.   
3.1.2 India  
India is an agricultural country and majority of people in our 
country are engaged in agriculture related activities like seasonal 
agriculture labours, dairy product selling and animal meat selling. Several 
studies and publications from India revealed that human brucellosis is a 
common disease. Studies conducted from various centers of India have 
reported seroprevalence ranging from 0.8 to 6.8% in patients with PUO.53  
A prospective study conducted in North India by Handa R et al 54 
observed that 3.3% patients with PUO had acute brucellosis while 6.6% 
had serological evidence of previous Brucella infection. 14% of the  
asymptomatic, 'at risk' individuals screened were seropositive for 
Brucella infection. 
Kadri SM et al 55 in  2000 observed that  out of a 3,532 hospitalised 
patients for  PUO 28 (0.8%) were found seropositive for brucellosis . 
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A study done  by Appanavar SB et al 56  in North India  revealed 
that  the seroprevalence of brucellosis in PUO cases  were 9.94% of 
which 45% had  acute infection and the remaining 55% had  chronic 
infection. 
Moti Yohannes et al 57   in 2011 had done a seroepidemiological 
survey of  human brucellosis  in and around Luthiana  among  241 high 
risk persons with and without pyrexia of unknown origin and the 
seroprevalence documented was 26.6%. In Orissa it was 6.8% 58 and in 
Andhra Pradesh it was 11.51%.  
A study conducted by Vaishnavi C et a l 59  reported that out  of 
292 serum samples of blood donors, 16.8% had positive Brucella  
antibodies  of this  0.36%  had high titres of antibodies. 
A Seroprevalence study conducted in Davangere, Karnataka60 
reported that the overall seroprevalence of brucellosis   was 3.3%. It was 
2.4% in general population and 11.1% in veterinary staff. In study from 
Kerala in 2005 61 reported that the overall seroprevalence of brucellosis 
was 1.6%. Among the general population the prevalence rate was 2.45% 
and in veterinary students  it was 1.14%.   
In Gujarat62 8.5% prevalence of 8.5%, in Belgaum 63   
seroprevalence of 8.5% in publics and 5.8 to 14.3% in veterinary persons. 
In another study in 2006, reported  a prevalence rate of 1.8% in Bijapur.53  
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Panjarathinam et al 64 reported the seropositivity of 6.5% in  
aborted women. The high incidence of spontaneous abortion may be due 
to the fact that  this organism infects the chorio amniotic tissue  
Persistence of infection in animal reservoir, low physician 
awareness, poor availability of diagnostic facilities, and the non existence 
of regional data bases contribute towards the perpetuation of this zoonosis 
in India, while it has been eradicated from most developed countries.  
3.2 Age 
Brucellosis affects all age groups. 
In a study, Fatima et al 65 observed that those who were in the age 
of 51 to 60 yrs had increasd seropositivity followed by of 41 to 50 yrs. As 
brucellosis is an occupational disease, individuals in this age were at a 
greater risk because of prolonged years of exposure. 
In a study by Ramos TRR in 2006 66 reported that there was a 
significant association between age group and seropositivity for this 
disease, with individuals above 40 years of age more predisposed to being 
infected, which is similar to the findings of Bigler et al 67 and  Feliciano 
et al reported that there is increased frequency of seropositivity  with 
advancing age, probably due to a longer  period of exposure to the 
organism. 
            A study from Karnataka, in 2007 68 noted that the highest 
prevalence of 45.36% was found in 41to50 yrs of age followed by 
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32.98% in the age of 31 to 40 yrs. 14.43% were in the age of 51 to 60 yrs. 
7.21% cases in the age of 21 to 30 yrs. This study reported that a wide 
variation in the age group of seropositives. 
Jama’ayah MZ  et al in 201151 found  in their study that persons 
were in the age of  20 to 45 yrs had higher seroprevalence. 70% were  in 
the age of > 40 yrs and  2% were  < 20 yrs of age.  
Mahmoud N Abo-Shehada et al in 1996 69observed in their study 
that seroprevalence of brucellosis increased with age. Among 26.3 % of 
seropositive veterinary surgeons  the  highest  prevalence  was noted in  
34-43 years of age . 
Metri Basavaraj C et al in 201160 reported that in veterinary 
surgeons, brucellosis was  more common among in the age group of 31-
40 years followed by persons more than 41 years. Randhawa et al 70  have 
reported that individuals in the age of thirty (14.2%) and forty years  
(7.0%)  had  the  highest prevalence among high risk persons. More 
prevalence in this age group may be due to increased activities with 
regards to their occupation, thereby increasing the risk of acquiring the 
infection.  
Ali et al 71 reported that  those were in the age  of 25 to 35 yrs had 
higher soprevalence.  Kadri et al 55 also observed that persons of 21 to 30 
yrs had the higher (43%) seropositivity.   
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A seroepidemiological study  done in 1999 39 revealed that  
seropositivity of brucellosis increases with age advances. The lower 
seroprevalence rates found in paediatrics may be  due to the fact that 
adults had the much exposure to animals. A study by Abu-Shehada et al69 
and Araj GF et al 41 reported an increase in   frequency of  seropositivity 
when the age advances.   
Ofukwu et al in 2004 52 in their study reported that  higher 
seroprevalence (38%) were  in the age of 21 to 40 yrs and 32.9%  in the 
age of  41to 60 yrs. 13.9% and 15.2% were in the age group of  0- 20 
years and in  the age group of 60 and above years. There was no 
significant association in the age specific prevalence rates. 
3.3 Sex 
Brucella affects both males and females equally. There is no sex 
wise discrimination between the two sexes provided they are equally 
exposed to the potential risk factors. But most of the studies reported that 
males are most commonly affected than females which is perhaps 
justified by the greater presence of men in the veterinary profession, 
slaughterhouses and dairy farms. 
A study from Malasyia 51  showed that seropositivity was common 
in (90%)  males than (10%) females.  
 Moti Yohannes et al 57 observed in their study that  all seropositive 
cases were men. Various other studies conducted by other researchers 
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also found that males were more commonly affected than females. This is 
due to the fact that males are employed in field of animal husbandry or 
are exposed to infected animals and their secretions. 
Kapoor et al in 198 72 and Hussein et al in 2005 73 reported  higher  
seropositivity among females.  
A study from Nigeria,52 reported that out of 79 Brucella positive 
cases, 45.6% were male and 54.4% were females. This results were in 
concordance with the  findings of Falade  and Junaidu et al. 74 
Aseroepidemiological survey of brucellosis among animal handlers 
38 revealed that seropositivity and gender was not significantly 
associated.75 A study by Al seikait 39 also reported that there was no 
significant difference between the sexes. 
A study by Ramos TRR in 2005 66 found that among the 26  
serology positive individuals  3 (2.0%) were females and 23 (4.7%) were 
males. There was no significant association between sex and 
seropositivity in the individuals studied. 
3.4 Education 
Low literacy is one of the risk factor for brucellosis because they 
are not aware of the zoonotic diseases and they don’t follow any hygienic 
practices after handling the animals and their products. Karimi et al76 
reported that significant association between low literacy and 
seropositivity. 
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Sumer et al 77 and  Fatima et al 65 found that  no association 
between the literacy and  seropositivity.  
3.5 Residential Background 
A study conducted in Lahore 65 reported that out of the 78 
seropositive individuals , 22.6%   were from urban localities and  20.3%  
from rural  areas. The residential background was not significantly 
associated with seropositivity. Baba’s et al 78 also reported the similar 
findings.  
Nabi et al 79  reported  that  84.2%  of seropositives reside in rural 
area  and 15.8% from urban areas. The increased prevalence  in rural 
people may be due to the fact that they are involved in cattle rearing and 
handling.68                  
In a study from different regions of Saudi Arabia,39 the 
seropositivity  was higher ( 26.2%)  in those from rural areas compared 
with (9.5%) in  urban areas. This may be due to the fact that ingestion of  
raw milk and their  products from infected animals as well as handling of 
aborted fetuses, placenta and uterus and vaginal secretions may be 
considered sources of infection for the high positivity of brucellosis 
among  the  rural population. 
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3.6 SocioEconomic status 
Al sekait 39 noted the highest (24.4%) seroprevalence  among the 
persons of low socioeconomic status when compared to the persons 
(6.3%)  of high socioeconomic status. 
3.7 Occupation 
         Meky et al reported that workers in occupations dealing with 
animals had a 2.4-times higher risk of acquiring the infection than those 
in occupation not dealing with animals.  
Brucella are detected  in the  abortive products and carcasses of 
infected animals and their secretions thus  brucellosis becomes an 
occupational disease for veterinary persons, slaughterhouse workers  and 
farmers.66 
Brucellosis is an occupational hazard to veterinary professionals. 
They are exposed to all risks except their awareness about the zoonotic 
disease. These persons usually acquire the disease by cuts in the skin and 
conjunctival splashes or through inadvertent injection of animal vaccine 
and during the removal of infected uterine products.1 
A study conducted in high risk group individuals  observed that the 
seroprevalence of brucellosis was 41.2% in  Live stock inspectors, 30.9% 
in veterinary assistants, 12.37% in veterinary doctors, 6.18% in 
supervisors and in sweepers, 2.06%, 1.03%  in shepherd and butchers 
respectively.68  
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In study by Thakur 80 reported the overall seroprevalence of 4.97%  
among animal handlers  of which veterinary surgeons (17.39%) had the 
higher seroprevalence.  
Mrunalini et al 81 reported  seroprevalence of  25.24% in 
veterinarians, 23.3% in para-veterinarians, 12.62% in farmers, 11.65% in 
shepherds and 6.8% in other occupational groups.  
A study conducted in the year of 2003 82 among animal handlers 
found that out of 225, 5.33% were seropositive. Among them 14.63% of  
veterinary doctors and  4.51 % of  dairy farms workers were  
seropositive. 
A seroprevalence study on persons of high risk occupation  
revealed that the veterinarians (50%) had the highest percentages of 
seroprevalence followed by  farmers who had a seroprevalence of 23.9 % 
and butchers had 9.2% prevalence rate.41 In Saudi Arabia, 7.14% of 
veterinary surgeons and  2 .67 % of butchers were positive for Brucella 
agglutinins.  
Dairy workers are exposed continuously to the pathogenic agent 
while  milking the animals because their hands get contaminated.82  
Eritrea, Omer et al reported 83 that the highest  prevalence  among 
dairy farm workers 7.1% and owners, followed by 4.5% in veterinary 
staffs. Soman and Kothari  reported that  4% of dairy workers  were 
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positive for Brucella antibodies. Sohaila et al reported the seroprevalence 
of  6.1% among dairy workers.  
Meat handlers, abattoires are in direct contact with carcasses of 
infected animals and raw meat are at greater risk. They are infected 
through abrasions and cuts in mucous membrane and splashes in  
conjunctival mucosa.  
Cadmus S.I.B et al 2006 48 found that the overall seroprevalence of 
brucellosis  was 31.82%. Of this 63.63% were butchers. Butchers are 
frequently   infected  might be due to the fact that  they do not use PPE 
and  exposed to infective material like blood, vaginal secretion, retained 
uterine products and  urine  from infected animals.  
A study by Kumar et al among abattoir workers 84 in which, blood 
collectors  had the highest (99.77%) seropositivity followed by, 68.96% 
among animal handlers, 68.00% in  butchers, 57.14% in sweepers and 
28.57%  were among the veterinary surgeons.             
A study conducted in  2004 52  revealed that  the seroprevalence of  
43.8% in  abattoir workers/ butchers. This was similar to the reports by 
Falade 1974, Ocholi 1993, Edu, 2005 the prevalence was  28 to 57% 
among abattoire workers . 
A study on seroepidemiological survey of brucellosis antibodies 
from various occupational groups in Saudi Arabia 39 stated that the 
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seroprevalence of was higher in occupationally exposed group such as 
meat sellers, veterinary professional and  farmers.  
In Pakistan, Masoumi et al85 carried a  study  among abbatoire 
workers and found the  seroprevalence   to be 8.33%.  In Algeria, the 
seroprevalence  was found to be 37.6% among high risk persons.  
Shepherds also at the risk of acquiring the disease due to the 
widespread infection of  Brucella melitensis in sheep.  
Sonmez et a observed the seroprevalence of brucellosis to be 6.2% 
among farmers in East Anatolia of Turkey. MH Salari  et al in 1997 75 
reported a seroprevalence of  3.75%  among animal farmers of Yazd 
province of central Iran. The poor hygienic practice favours the 
transmission of infection among farmers 
A seoprevalence study done in high risk group showed that  
significantly higher seropositivity of 8.2% among  high risk groups.64  
Asanda 86  reported that seropositivity was  increased  in persons 
who are involved in livestock and  their product activities than those in 
other productive activity.39 A study of  Detection of Brucella abortus 
antibodies in animal handlers in Pune by S Mudaliar et al 2003 82 found 
that  out of 225 animal handlers screened, 15.33% were positive for 
Brucella antibodies. 
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3.8 Duration of work 
A study  from  Northern Jordan observed that the seropositivity of 
brucellosis was significantly  high in  persons those who are 
occupationally  exposed to animals for  more than 22 yrs  when compared 
to  people having  work of  less than 22 years.69 
Karimi et al 76 and Sohaila et al reported strong correlation 
between the seropositivity and duration of exposure to animals. 
3.9 Other Risk factors  
Brucella infection is transmitted to humans through the 
consumption of raw milk or unheattreated dairy products.   
Hasanjani Roushan etal 2 and Al-Fadhli et ai Observed that 
consumption of fresh cheese, unpasturised milk as the risk factor.39    
          Ali et al 71and Al Sekait 39 reported contact with animals, raising 
animals in the vicinity of residence and drinking unpasteurised milk as 
risk factors. 
3.10 Vaccination 
Animal vaccines are being used with increasing frequency to 
protect the health of live stocks. However, the persons who are handling 
the vaccines get exposed by means of inadvertent inoculation or  by other 
routes.  During the vaccination of animals accidental human inoculations 
can occur. Studies reported that there are few reports of adverse events in 
persons associated with the use of animal vaccine. 
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The attenuated strain of  B. abortus S19 is the vaccine commonly 
used to prevent animal brucellosis. Nowadays rough mutant strain RB51, 
replaces the S19 vaccine because it is less virulent and will not interfere 
with serological tests. Though they are less virulent, both are infectious to 
humans. Human get infected through conjunctival splashes, cuts in skin 
and mucous membrane or via   infectious aerosols. 
J. C.Wallach 87 conducted a  survey  to evaluate the consequences 
of exposure to the vaccine strain Br. abortus S19 from employees of 
vaccine-manufacturing plants in Argentina  and the results revealed that  
active  infection was  observed in 30%  of individuals, out of  which 5 
(23.8 %) were given a history  of accidental exposure to the vaccine. 
Ashford DA et al 88 reported  in their study  that 81% of  
individuals  got a   accidental exposure to RB51 vaccine  by needle stick 
injury, 15% by  conjunctival  splash, and  4%  by   cuts in skin and 
mucous membrane among the persons who handled the live cultures or 
participated in the vaccination of animals.  
A seroepidemiological study conducted by Moti Yohannes et al 57 
reported that among the veterinarians, seroprevalence of brucellosis  was  
significantly high   in those who  participated  in vaccination of animals 
against brucellosis than those who did not.  
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3.11 Diagnosis 
The heterogenous type of clinical symptoms, paucity of clinical 
signs and  the presence of subclincal and atypical infections makes the 
clinical diagnosis difficult. Isolation of  bacteria and  the serological 
evidence of infection are vital to confirm the clinical diagnosis. 
In acute stage of disease,  IgM  agglutinins  starts to appear  within 
a few days  of infection and the peak level is reached after one month. 
IgG antibodies may be detected after 10 days and it attains the peak level  
8 weeks after the infection.  In acute stage of the disease The IgM  level 
always exceeds the IgG antibody level. There is sustained production of 
IgG agglutinins in subacute and chronic stage of brucellosis.1  
A natural survey conducted in Saudi Arabia to asses the  
seroprevalence of brucellosis  and the results revealed that out of 23,613 
persons participated in the study ,  3558  (15.0%) gave a positive reaction 
with STAT.39 
While screening 292 blood donars  in Chandigarh by slide 
agglutination method for brucella only one ample was positive and one 
was  inconclusive.  Of the above 292 samples 273 were screened for the 
presence of brucella antibodies by STAT. Only one sample was found to 
be positive at 1in160 dilution.59 
Ofukwu et al 52 conducted a study among hospitalized patients in 
North central Nigeria, a total of 1040 samples were screened using the 
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RBPT and STAT. Of this 79 (7.6%) were seropositive by RBPT. The 
RBPT positive samples were  further tested by STAT and 57 showed 
agglutination. The sensitivity of both these test are same.  
The ELISA the advantage of identifying different classes of 
antibodies in comparison to other agglutination methods. This situation 
has an effect on the sensitivity, specificity and ultimately applicability of 
the method. This tests are relatively costlier tests in comparison to 
agglutination tests that requires equipment and experience. 
The study conducted by Fatima et al in 2008 at Lahore, Pakistan65 
reported that the seroprevalence of Brucellosis among  abattoir workers  
estimated using ELISA technique was 21.7%.  
Kostoula et al 89 reported that when compared to the STAT, ELISA  
is  most  sensitive in the diagnosis of human brucellosis, because  it 
detects IgM, IgA and IgG.    
Ariza et al29   reported that ELISA was a most sensitive and specific 
technique  than   SAT for the diagnosis of human brucellosis. Gazapo et 
al 90 stated that IgM and IgG ELISA can be used for epidemiological 
investigations. 
Agasthaya et al 68 reported  that out of 618 samples screened, 
2.26%.2.26% and 15.69% were positive by STAT, RBPT and ELISA  
respectively. However, the overall prevalence was 15.69% by indirect 
ELISA. This ELISA has  high sensitivity and specificity.  
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Hassan JS  et al reported that ELISA was  the most appropriate test  
when compared with STAT because ELISA  detects more IgG positive 
cases than STAT.  
Orduna et al 37 conducted a study and the results revealed that the 
sensitivity of Immuncapture agglutination test, Coombs test in STAT in 
the diagnosis of brucellosis  was found to be 95.1 %, 91.5 % and 65.8 % 
respectively. 
In a comparative study conducted by Prado et al 91 Brucella capt, 
STAT and Coombs anti-Brucella test were compared with Ig G, Ig A and 
Ig M ELISA tests.The sensitivity and specificity of Brucellacapt and 
Coombs anti-brucella were similar to one another.  In the follow-up of 
the treatment, the antibody titers determined via these tests were close to 
ELISA and it was concluded that they were well correlated. 
Mantur B et al 31 conducted a study in a 92 patients having 
presumptive diagnosis of brucellosis and the diagnosis was confirmed by 
blood cuture, STAT, 2-ME and ELISA. Blood culture was positive in 31 
(33.6%), STAT in 23 (25%) cases, and 2-ME was positive in 21( 22.8%) 
whereas ELISA IgM and IgG together were found positive in 56 (60.9%) 
cases. The sensitivity and specificity for ELISA were found to be 100% 
and 71.31% respectively. A statistically significant difference was noticed 
in the performance of ELISA over traditional agglutination tests.  
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A comparative study conducted by Araj et al 35argued that the 
ELISA method should be preferred because in chronic and complicated 
cases, STAT and Rose Bengal tests might miss a serious portion of 
positive cases 
A comparative study of laboratory diagnostic tests of human 
brucellosis by Sathyanarayan MS et al 92 found that among the  cases of 
PUO, none of them grew any isolate of Brucella in  blood cultures. Seven 
were seropositive by agglutination tests and 13 of the 42 cases yielded 
positive results with ELISA .Serological tests are more sensitive as 
compared to blood culture. ELISA is the most sensitive test . 
Vaso Taleski 93  conducted a study to analyse the various 
diagnostic methods of human brucellosis from patients at different stages 
of the disease showed the sensitivity of culture  was 17.7%, RBPT 96%, 
STAT 84%, Coombs 86%,  cELISA 98%, ELISA 98%, and - Specificity 
of: culture 100%, RBPT 97%, SAT 100%, Coombs 100%, cELISA 98%, 
ELISA 100%.  The test results revealed that ELISA is the best serological 
test for diagnosis of human brucellosis.  
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4. MATERIALS AND METHODS 
              The present study was conducted at Tirunelveli Medical 
College and Hospital, Tirunelveli, Tamilnadu  from September 2011  to 
August 2012 to detect  the  seroprevalence of brucellosis by measuring 
the Brucella IgG antibody  by ELISA. 
4.1 Materials 
4.1.1 Study population 
 a. Animal handlers. 
A total of 130 blood samples from veterinary surgeons, veterinary 
hospital workers and farmers of Tirunelveli district  were collected.  
b. Control group 
A total of 130 blood samples were collected from Doctors, Post 
graduate students, lab technicians and clerical staffs of Tertiary care 
hospital of Tirunelveli. 
Thus a total of 260 individuals participated in this study. 
4.1.2 Ethical clearance    
As this study involved collection of blood from human beings, 
ethical committee   clearance   was obtained before the commencement of 
the study. 
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4.1.3 Informed   consent 
Informed consent was obtained from all the persons who were  
involved in this study  before  blood collection. 
4.1.4 Questionnaire 
A questionnaire was used to obtain information  from the study. 
(Annexure-I )   
4.1.5 Sample collection and serum separation 
About 3-5 ml of venous blood was collected from all the persons 
who involved in this study with aseptic precautions in sterile collection 
tubes and labelled properly. They were allowed to clot at room 
temperature for 30 minutes. 
4.1.6 Storage of serum 
Serum samples were stored at -20°C in deep freezer until testing. 
Repeated freezing and thawing was avoided. 
4.1.7 Bio medical waste management 
As the materials handled were highly infectious, proper biomedical 
waste management according to the regional guidelines was followed 
throughout the study. 
4.2 ELISA kit 
ELISA kit for Brucella IgG estimation was purchased from Vircell, 
Granada, Spain. 
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4.2.1 Principle  
This ELISA method works on the principle that antibodies in the 
sample reacts with the antigen adsorbed on the polystyrene surface. 
Those unbound immunoglobulins are washed off. To this antigen – 
antibody complex, an enzyme-labelled anti-human globulin binds. Finally 
the substrate binds to the  entire complex  forming  blue coloured soluble 
product which turns into yellow after adding the 0.5M sulphuric acid. 
4.2.2 Contents of the kit 
Vircell brucella plate 
96 wells plate coated with LPS antigen of B. abortus,strain S-99. 
Serum diluent  
Phosphate buffer containing protein stabilizers and proclin. 
IgG positive control 
Positive control serum.  
IgG cut off control   
Cut off control serum  
IgG negative control 
Negative control serum . 
IgG conjugate  
Anti-human IgG  peroxidase conjugate dilution in an orange-
coloured proclin-containing buffer.  
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TMB substrate solution  
Substrate   solution containing TetraMethyl Benzidine (TMB). 
Stop reagent 
0.5 M H2SO4. 
Wash buffer 
20x washing solution, a phosphate buffer containing TweenR-20. 
and proclin. 
4.2.3 Storage of kit  
All the kit contents were stored at 2-8ºC.  
4.3 Estimation of Brucella IgG Antibody by ELISA 
4.3.1Requirements  
¾ Kit contents 
¾ Serum samples 
¾ 5 μl and 100 μl  micropipettes 
¾ 100 μl 8 channel micropipette 
¾ Micro tips, adhesive slips 
¾ ELISA washer 
¾ Thermostablised  incubator or water bath 
¾ Spectrophotometer with a 450 nm measuring filter and a 620 nm 
reference filter 
¾ Distilled water 
¾ Disposable gloves, absorbent papers, absorbent pad 
¾ Disinfectant solution, black cover. 
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4.3.2 Preparation of the washing buffer 
Distilled water was added to 50 ml of 20x washing solution and 
made upto 1 litre. The diluted wash buffer was stored at 2-8ºC. 
4.3.3 Pre-requisites 
¾ Incubator was set with 37±1ºC. 
¾ All the reagents were brought to room temperature before use. 
¾ The  kit  reagents were mixed thoroughly. 
4.3.4 Procedure 
¾ Plates were removed from the package. 
¾ The samples were pre diluted in a separate tube, by adding  200 μl 
of serum diluent with 10 μl of sample. It was mixed  
homogenously with the pipette.  
¾ First four wells were used for the controls - one for negative 
control,  two for  cut off serum and one for  positive control. 100 μl 
of serum diluent was added to all the four wells and   5 μl of 
corresponding control sera were added. 
¾ 105 μl of each diluted sample was dispensed  into the appropriate  
wells. The plate was sealed and incubated at 37±1º C for 45 mints. 
¾ The plate was washed with the diluted washing buffer for five 
times with the help of ELISA washer. Then the plate was blotted 
dry by tapping firmly onto absorbent paper.  
¾ In each well, 100 μl of IgG conjugate solution was added. 
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¾  The ELISA plate was sealed and incubated at 37±1ºC for 30 mints. 
¾ The seal was removed and the plate was washed with the diluted 
washing buffer for five times  with the help of ELISA washer. 
Then the plate was blotted dry by tapping firmly onto absorbent 
paper. 
¾ Then 100 μl of TMB substrate solution was added in all wells and 
incubated  at RT for 20 mints  and protected from light by keeping 
the plate in the dark environment. 
¾  In each well, 50 μl of 0.5M H2SO4 was added and the it was read 
with a help of ELISA reader with spectrophotometer at 450/620 
nm within 1 hour of stopping the reaction. 
4.3.5 Validation protocol  
 
 CONTROL               OD 
Positive control > 0.9 
 Negative control < 0.55 
Cut off control 
< 0.7 x (O.D. Positive control) 
>1.5 x (O.D. Negative control) 
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4.3.6 Interpretation of results 
The mean O.D. for cut off serum was calculated. 
Antibody index = (sample O.D./ cut off serum mean O.D.) x 10 
 
Index Interpretation 
< 9 Negative 
9-11 Equivocal 
> 11 Positive 
 
¾ Samples with equivocal results were repeated 
¾ Samples with index  < 9 were considered  negative for IgG 
specific antibodies against Brucella.        
¾ Samples with index > 11 were considered as positive for IgG 
specific antibodies against Brucella.         
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5. RESULTS 
5.1 Study population 
5.1.1 Animal handlers 
A total of 130 animal handlers were included in this study. They 
were veterinary surgeons and veterinary hospital workers who were 
working in and around Tirunelveli district and farmers who were residing 
in the same area. The study period was from September 2011 to August 
2012.    
5.1.2 Control group 
        A total of 130 non animal handlers were included in this study as 
controls. They were Doctors, Post graduate students, Laboratory 
technicians and Clerical staffs of Tertiary care hospital, Tirunelveli. 
5.2 Statistical Analysis 
The animal handlers were divided into two groups according to 
their Brucella IgG ELISA positive and negative results. They were 
matched according to their age and gender. The continuous variables 
between the two groups were compared by Student’s unpaired ‘t’ test and 
the categorical variables were compared by χ 2  (Chi-square) test.  The 
above statistical procedures were performed by the statistical package 
IBM SPSS statistics -20. The P values <0.05 determined the significance 
in two tailed tests. 
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Table-1 Occupation wise distribution of animal handlers. 
 
S.No Occupation 
No. of 
participants 
Percentage 
1. Veterinary surgeons 80 61.5 
2. Veterinary hospital 
workers 
45 35.6 
3. Farmers 5 3.9 
 Total 130 100 
 
 
       The above table shows, among the 130 study population, 80 (61.5%) 
were veterinary surgeons, 45 (34.6%) were veterinary hospital workers 
and 5 (3.8%) were farmers.(Fig-1)  
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Table-2 Occupation wise distribution of control group 
 
S.No Occupation 
No. of 
participants 
Percentage 
1. Doctors 34 26.1 
2. Post graduate 
students 
42 32.3 
3. Lab.Technicians 21 16.1 
4 Clerical staffs 33 25.4 
 Total 130 100 
  
 
          Table -2 shows, out of 130 participants in the control group, 
34(26.1%) were Doctors, 42(32.3%) were post graduate students , 21 
(16.1%) were lab technicians and 33 (25.4%) were clerical staffs. (Fig-2) 
 
 
 
 
  
Fig. 
Fig
Assista
1 Occupa
.2 Occup
35.6%
Veterina
16.1%
nt professors
tion wise
ation wis
ry surgeons
25.4%
Post grad
51 
 distribut
e distribu
3.9%
Veterinary 
uate student
ion of an
tion of co
hospital work
3
s Lab.Tech
imal han
ntrol gro
61.5%
ers Farme
26.1%
2.3%
nicians C
dlers 
up 
rs
lerical staffs
 
 
52 
 
 
Table- 3.Age and Sex wise distribution of animal handlers 
 
.Age 
( years) 
Male Female Total 
No % No % No % 
25-34 13 11.3 6 40 19 6.1 
35-44 35 30.4 8 53.3 43 17.7 
45-54 56 48.7 0 0 56 43.1 
55-64 11 9.6 1 6.7 12 33.1 
Total 115 100 15 100 130 100 
 
 
Among the 130 participants,115 (88.5%) were males and 15 
(11.5%) were females. Of this 13 (11.3%) males and  6 (40%) females 
were in the age group of 25-34 years, 35 (30.4%) males and  8 (53.3%)  
females were in 35-44 years, 56 (48.7%) males and none of the females 
were in the age group of 45- 54  and 11 (9.6%)  males,  one (6.7%) 
female was  in the age group of 55- 64 years. The mean age of the animal 
handlers was 44.5±8.3 years More males were in the age group of 45-54 
years. (Fig-3) 
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Table-4  Age and Sex wise distribution  of  control group. 
Age 
( years) 
Male Female Total 
No % No % No % 
25-34 22 31.0 36 61.0 58 44.6 
35-44 33 46.5 17 28.8 50 38.5 
45-54 14 19.7 6 10.2 20 15.4 
55-64 2 2.8 0 0 2 1.5 
Total 
 
71 
(54.6%) 
100 
59 
(45.4%) 
100 130 100 
 
 
Among the 130 participants,71(54.6%) were males and 59 (45.4%) 
were females. Of this 22 (31%) males and 36 (61%) females were in the 
age group of 25-34 years, 33 (46.5%) males and 17 (28.8%)  females 
were in 35-44 years, 14 (19.7%) males and 6 (10.2%) females were in the 
age group of 45- 54  and 2 (2.8%)  males and none of the females were  
in the age group of 55- 64 years. (Fig-4)  
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Table-5 Brucella IgG positives and negatives among the animal 
handlers and control group. 
 
     Brucella IgG 
ELISA Test 
Animal handlers Control group 
No % No % 
Positive 19 14.6 0 0 
Negative 111 85.4 130 100 
Total 130 100 130 100 
 
 
 The above table describes out of 130 study group, 19 (14.6%) 
were positive for Brucella IgG antibody and 111 (85.4%) were negative 
for IgG antibody. Among the 130 control group none were positive for 
Brucella IgG antibody. Seropositivity between animal handers and 
control group (non-animal handlers) was staistically significant ( P< 
0.0001). (Fig-5) 
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Table- 6. Gender wise distrbution of seropositives and seronegatives 
among animal handlers. 
 
Brucella IgG ELISA 
Male Female 
No % No % 
Seropositive n =19 18 94.7 1 5.3 
Seronegative n=111 97 87.4 14 12.6 
               
The above table shows, out of the 19 seropositive individuals 18 
(94.7%) were males and one (5.3%) was  female. Among the 111  
seronegatives 97 (87.4%)  were males and  14 (12.6% ) were  females.  
The results revealed that there was no significant association of 
seropositivity between males and females. (P>0.05) (Fig-6) 
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Table - 7. Age wise  distribution of seropositives and seronegatives 
among animal handlers. 
 
Age 
(years) 
Positive Negative 
No % No % 
25-34 0 0.0 19 17.1 
35-44 3 15.8 40 36.0 
45-54 11 57.9 45 40.6 
55-64 5 26.3 7 6.3 
Total 19 100.0 111 100.0 
    
 
              Table -7 shows that the maximum number seropositives 
11(57.9%) were  in the age group of 45-54 years. The mean age of the 
seropositive individual was 50.4 ± 4.6 and the same of the  seronegative 
was 43.5 ±8.4 years. The difference between them was 6.9 years and the 
age was statistically significant (P<0.01).(Fig-7) 
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Table-8. Occupation wise distribution of seropositives and 
seronegatives among animal handlers. 
 
 
Occupation 
Seropositive Seronegative 
No % No % 
Veterinary Surgeon 11 57.9 69 62.2 
Vet. Hosp. Workers 8 42.1 37 33.3 
Farmers 0 0.0 5 4.5 
Total 19 100 111 100 
 
 
The above table describes, among the 19 seropositives 11 (57.9%) 
were veterinary Surgeons and 8 (42.1%) were veterinary hospital 
workers. None of the farmers were positive for IgG agglutinins.  
Among the 111( 85.3%) seronegatives 69 (62.2%) were veterinary 
surgeons, 37 (33.3%) were veterinary hospital workers and 5 (4.5%) were 
farmers. The test results revealed that there was no significant association 
of seropositivity between the   veterinary surgeons and veterinary hospital 
workers. (P>0.05).(Fig-8) 
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Table - 9. Description and comparison of duration of exposure to 
animals 
 
Duration of exposure 
(years) 
Seropositive Seronegative 
No % No % 
5-14 1 5.3 40 36.0 
15-24 8 42.1 45 40.6 
25-34 10 52.6 21 18.9 
35-44 0 0.0 5 4.5 
Total 19 14.6 111 85.4 
 
 
The duration of exposure to animals between the seropositives and 
seronegatives is shown in table-6.The more number of 10 (52.6%) 
seropositives had the duration of exposure of > 25 years. The mean 
duration of  exposure in brucella seropositives was 25.3±5.0 years and  
the same in  seronegative was 18.0 ± 7.9 years. The difference between 
them was statistically significant (P<0.001). (Fig-9) 
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Table- 10.  Handling of animal vaccine for Brucella  among animal 
handlers. 
 
Handling of Brucella 
vaccine 
Positive Negative Total 
No % No % No 
Yes (Handled) 13 68.4 8 7.2 21 
No (  did Not handle) 6 31.6 103 92.8 109 
Total 19 100 111 100 130 
 
Table-10 describes, among the130 animal handlers  21 had handled 
the brucella vaccine for animals and 109 had not handled the vaccine. 
Out of the 21 vaccine handled persons13 were seropositive and  8 were 
seronegative for Brucella IgG antibody. 
             Among the 19 seropositives, 13 (68.4%) had handled the vaccine 
and 6 (31.6%)  had not handled the vaccine. Out of  111 seronegatives  
only 8 (7.2%) had handled the vaccine and 103 (92.8%) had not handled 
the vaccine. Thus the association between handling of vaccine and 
seropositivity is statistically significant (P<0.0001). (Fig-10) 
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Table- 11. Consumption of raw dairy products among animal 
handlers. 
 
Raw dairy 
consumption
Positive Negative Total 
No % No % No 
Yes 11 57.9 25 22.5 36 
No 8 42.1 86 77.5 94 
Total 19 100 111 100 130 
 
 
Among the total of 130 study group, 36 had history of consumption 
of raw dairy products and  94 had no such history. 
Out of the total 19 brucella IgG positives, 11(57.9%) had 
consumed the raw dairy products and  8 (42.1%) had not consumed the 
products. Among the111 seronegative individuals,  25 (22.5%) had  the 
history  of consumption and 86 (77.5%)  had not consumed the raw dairy 
products. The test results revealed that there was significant association 
between seropositivity and consumption of raw dairy products. (Fig-11) 
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Table- 12. Awareness  of  brucellosis  among animal handlers. 
 Awareness 
of brucellosis 
Seropositive Seronegative Total 
No % No % No 
Yes 11 57.8% 95 85.6 106 
No 8 42.2 16 14.4 24 
Total 19 100 111 100 130 
 
 
Table -12 shows, among the 130 animal handlers 106 were aware 
of the disease and   24 were not aware of the disease.  Among those who 
were aware of the disease 11 were seropositive and 95 were negative for 
brucella IgG antibody. Out of 24 persons who were not aware of the 
disease 8  were positive and 16 were negative. 
               Among   the total 19 IgG positive individuals, 11 (57.8%)  were 
aware of the disease and 8 (42.2%)  were not aware of the disease. Out of 
the 111 seronegatives  95 (85.6%) were aware of brucellosis and 16 
(14.4%) were not aware of it. There was significant (P<0.001) association 
between awareness of disease and decreased seropositivity. 
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Table-13. Socio  demographic  profile of seropositives. 
                
Table-13 summarises the important sociodemographic profile of 
the total 19 Brucella IgG  positive animal handlers  and their significance 
in association with the disease.          
 
S.No Variable Total 
ELISA positive 
P value 
No % 
1. Age group in years  
 25-34    19 0 0 
35-44    43 3 69.8 
45-54   56 11 19.6 
55-64    1 5 20.0 
2. Sex 
P>0.05  Male    115 18 15.6 
Female    15 1 6.7 
3. Duration of animal  exposure 
P<0.001 
 5-14   41 1 2.4 
15-24    53 8 15.1 
25-34   31 10 32.2 
35-44    5 0 0 
4. Handling of brucella vaccine for animals 
P<0.0001  Yes (Handled)    21 13 61.9 
No (Not handled)    109 6 5.5 
5. Awareness of disease 
P<0.001  Yes   106 11 10.4 
No    24 8 3.3 
6. Raw dairy products consumption 
P<0.001  Yes    36 11 30.5 
No    94 8 8.5 
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6. DISCUSSION 
6.1 Study population 
               130 animal handlers ( high risk group) and 130 controls were 
included in the present study to detect the seroprevalence of brucellosis.   
             In the high risk group, 80 ( 61.5%) veterinary surgeons, 
45(35.6%) veterinary hospital workers and 5 (3.9%) farmers of 
Tirunelveli district , were tested for seroprevalence of  brucellosis. It 
consisted of more males (88.5%) than females (11.5%) and many (56)  
participants were in the age group of  45-54 years. 
            In the control group, 34 (26.1%)  Doctors, post graduate students, 
21(16.1%)  lab technicians and 33(25.4%) clerical staff were included. 
This group comprised of more males ( 54.6%) than females (45.4%). 58  
participants were in the age group of 25 – 34 years and 50 were in the age 
group of 35-44 years . 
 6.2 Seroprevalence 
The seroprevalence  of brucellosis was found to be 14.6 % among 
these  animal handlers which is suggestive increased  exposure to 
Brucella species.  In the control group the seroprevalence was found to be 
nil. This could be due to the fact that the control group had no 
occupational contact with animals and also because of an urban life style 
and  safe hygienic measures like  consumption of pasturised dairy 
products. On the other hand, the animal handlers  may have developed 
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increase in titre of humoral antibodies as a result of repeated exposure to 
the agent. 
The disease produced  by Brucella results in protean clinical 
manifestation  and low mortality. However, the morbidity of brucellosis 
is high  because the disease process is long and incapacitating. In this 
study, all of  the screened individuals  were asymptomatic. The Brucella 
antibodies detected in asymptomatic individuals may be due to a history 
of repeated exposure to antigenic stimuli or  inactive brucellosis. 
The ELISA test which was used to detect IgG antibodies in the 
present study is very sensitive. This method  can  be used for the 
detection of  immunoglobulin isotypes and gives better interpretation 
regarding   the clinical situation and overcome the false negative and  
false positives which may arise in agglutination tests. More over this test  
is  suited for screening large number of samples.  
These antibodies seems to persist for a longer period or until they 
maintain contact with infected animals. This finding  was similar to the 
studies among high risks group persons by Agasthya et al (15.69%) in 
Karnataka, 68 Bhat et al (5.8 to 14.3% ) in Belgum 63 and Alsekait (15%) 
in Saudi Arabia.66 Reports from various developing countries in 
Mediterranean basin revealed that  the seroprevalence ranged from 8% in 
Jordan 40 to 12 % in Lebanon and Kuwait,41,42 18% in Uganda and 13% 43 
in Nigeria. 
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In comparison to other studies by Fatima Mukhtar (21.7%) in 
Pakistan,65 Rana et al (27.7%),  Kumar et al (28.57%) 84 and Cadmus 
S.I.B et al (31.82%)48 in Ibadan, Southwestern Nigeria, the 
seroprevalence in the present study was low. This could be due to the 
difference in geographical location, variation in existence of disease 
among animals and personal hygienic practice and social habits. 
But  the  seroprevalence was found to be high when compared to 
few Indian  studies done by Thakur and Thalipal (4.97%) in Uttaranchal80 
and Ajay et al (1.14%) in Kerala.61  This could be because of  intense 
agricultural activities, cattle rearing, dairy farming  and close contact with 
animals in the study  area.  
6.3 Sex 
In the present study the seropositivity was found to be higher in 
males (94.7%) than  females (5.3%).  This is in concordance with the 
study done by A.S. Agasthya et al  in Karnataka,68  Jama ayah MZ  et al 
in Malaysia51  and  Moti Yohannes et al in Ludhiana 57 where prevalence 
was more common among  males  than females.  Whereas Kapoor et al 72 
and Hussein et al 73  reported  in their study that increased seropositivity  
in females  when compared to males. However in the present study 
seropositivity between male and females was not  statistically  significant, 
which may be due to less number of females in the occupationally 
exposed study group. 
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6.4 Age  
The seroprevalence of Brucellosis  among animal handlers in the 
present study was highest in  45-54  (57.9%)  years of age.Agasthya  et al 
68 reported  highest prevalence of 45.36% among 41-50 years age group 
and Fatima et al 65 observed that  the highest number of seropositives 
were in the age of  51 to 60 years . Ramos et al,66 Jama’ayah MZ et al 51 
reported  that, animal handlers those who were in the age of 40 and above 
years had the highest prevalence. Whereas  Kadri et al 55 reported that 
those were in the age  of 21 to 30 years had  increased (43%)   
seropositivity.  
As brucellosis is an occupational disease, animal handlers > 40 
years are at a greater risk of acquiring the disease due to prolonged 
duration of exposure  to live stocks.  The present study showed there was 
significant association between age group and seropositivity of disease. 
6.5 Occupation 
In the present study , 57.9% of  veterinary surgeons and 42.1% of 
veterinary hospital workers were positive for brucella antibody. This is in 
concordance with the study done by  Araj GF et al 41  who reported  that  
veterinary surgeons had the highest prevalence (50%) among the 
occupationally exposed group. Agasthya et al 68 also observed that 59.8% 
of veterinary professionals  and 37.1% of veterinary hospital workers had  
positive serology for  Brucella antibody. The high prevalence rate among 
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this group may be due to the fact that brucellosis is an occupational 
hazard to the veterinary professionals. Even though they are aware of the 
disease, they acquire  brucellosis by  cuts in the skin or splashes into the 
conjunctiva  while handling the animal products and during  intravaginal 
or intrauterine manipulations in infected animals or by accidental 
inoculation of animal vaccines.      
Cadmus S.I.B et al 48 reported that butchers (63.63%)  had the 
highest seroprevalence  among the high risk groups. A study among 
abattoir workers in which, blood collectors had the highest (99.77%) 
seropositivity followed by 68.00% in butchers.84 Abattoire workers and 
meat handlers  who are in direct contact with carcasses of infected 
animals and raw meat have more chances of getting infection.  
Farmers usually reside in close proximity with their livestocks. 
They get infection by contact with infected animals and also by handling 
the infected placenta, its membranes and their discharges. During the 
burial of the products of conception their hands and forearms get 
contaminated. However in this study seropositivity  was not detected 
among farmers. It may be due to the fact that only few farmers were 
included in this study and also they were not exposed to the infected 
animals and their products.  
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6.6 Duration of work 
In the present study 52.6%  of seropositive individuals had worked 
in this profession for more than 25 years and 47.4% of  them had worked 
less than 25 years. Similar results were obtained by Abo-Shehada etal69 
where the seropositivity of brucellosis was significantly high among  
those  people who had worked  for more than 22 years of duration. 
Karimi et al76 and Sohaila et al reported strong correlation between the 
seropositivity of brucellosis and duration of work.  
This is because many veterinary professionals have a long duration 
of practice in this field of veterinary medicine which brings them in close 
contact with animals. There is a strong correlation between duration of 
work and seropositivity in the present study. 
6.7 Handling of animal vaccine for Brucella 
In the present study 68.4% of seropositives  had  participated in 
vaccination  of animals. There is a strong association between the  
participation in vaccination  of animals  and seropositivity. This is similar 
to the study by Moti Yohannes A et al57 and Ashford DA et al 88 who 
reported significantly increased seroprevalence of brucellosis  among the 
veterinarians  who  participated  in vaccination of animals than those who 
did not.   
  The animal vaccine is prepared from the attenuated strain   B. 
abortus  S19  and is most commonly used to prevent animal brucellosis. 
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The high rate of seroprevalence among vaccine handlers would have been 
due to accidentally acquiring the infection through conjunctival splashes, 
cuts in skin and mucous membrane and infectious aerosol. 88 
6.8 Consumption of raw dairy products 
In the present study 52.9% of seropositive individuals had 
consumed the raw dairy products . This was similar to the findings by  
Baba et al, 78 Hasanjani Roushan et al and  Al-Fadhli et al observed that 
consumption of unpasturised dairy products was significantly associated 
with high seropositivity.There was significant association between 
seropositivity and consumption of unpasturised dairy products.1 
Raw milk may also transmit other diseases to humans like bovine 
tuberculosis, salmonellosis and campylobacteriosis. Thus pasteurization 
of milk is an integerated control measure for multiple pathogens. 
6.9 Awareness of brucellosis 
In the present study out of the the 130 animal handlers, 106  were 
aware of the disease and 24 were not aware of the disease. 85.6 % of 
seronegative individuals were aware of brucelloisis All the veterinary 
surgeons and some of veterinary hospital worker were aware of  
brucellosis. There was significant association between awareness of 
disease and  low seropositivity. This  low seropositivity in persons who 
were aware of the disease may be due to the practice of proper hand 
hygienic measures and using personal protective equipments while 
76 
 
handling livestocks and their products.65 Moti Yohannes et al 57  reported 
significant association between awareness of  brucellosis and positive 
serology among high risk groups. 
Brucella  is one of the agent  likely to be used  as a biological 
weapon due to the fact that transmission through a spray is possible. It is 
a highly contagious bacteria and less than 100 organisms would be 
sufficient to produce infection in humans. 
There is no vaccine for prevention brucellosis in humans.  Human 
brucellosis should be controlled by vaccination of animals.   Animal 
owners should  be educated  about the importance of vaccination   of 
animals. Mass vaccination of cattles along with other measures such as 
screening and quarantine of infected live stocks can efficiently control the  
brucellosis in livestocks, thereby eventually  reducing the transmission of 
infection  to  human population. Awareness about the preventive 
measures like barrier protection methods, hand hygiene   should be 
created among the high risk persons  in order to reduce the transmission 
of infection from animals to humans.1  
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7. SUMMARY 
            The present study was aimed at assessing the seroprevalence of 
brucellosis in Tirunelveli district of Tamil nadu and to analyse the risk 
factors  associated with this disease. 
           130 controls and  130 animal handlers  were included in the study. 
Blood samples were collected and brucella IgG antibodies were tested by 
the method of ELISA and the results were analysed. 
¾ More number of participants were males  in both groups. 
¾ Among animal handlers most of them  were in the age group of 45-54 
years. 
¾ Seroprevalence in the control group was nil. 
¾ The seroprevalence among animal handlers was 14.6% 
¾ Gender was not significantly associated with  seropositivity. It may be 
due to less number of female  veterinary professionals. 
¾ Maximum number of seropositive  cases occured in the 45-54 age 
group. The mean age of the seropositive  individual was 50.4 ± 4.6. 
¾  All the animal handlers included in this study  were  at risk 
irrespective of their nature of work. 
¾ Duration of exposure to animals and handling the animals was a 
significant risk factor.  Those who had the exposure of more than 25 
years were at great risk. The mean duration of exposure for 
seropositivity was 25.3±5.0. 
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¾ Handling the animal vaccine for brucella was a significant risk factor. 
B.abortus  RB 51 is a live vaccine and the handlers get infected by 
inadvertent inoculation, conjunctival splashes and through aerosols. 
¾ Consumption of raw dairy products was significantly associated with 
the seropositivity of brucellosis. 
¾ Awareness about  brucellosis and its route of transmission  had an 
impact on with seroprevalence. The prevalence was low among the 
persons who were aware of the disease.  
¾ The lack of human vaccine and effective control measures make it 
necessary for the  veterinary  health personnel, animal husbandary 
workers  and health care providers to take protective measures. 
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8. CONCLUSION 
¾ The present study showed a significantly higher seroprevalence among 
animal handlers compared to the controlgroup.  
¾ Occupationally exposed persons to animal were at greater risk of 
acquiring brucellosis. 
¾ Higher age groups, long duration of exposure to animals,  handling  
and participation in vaccination of animals and consumption of raw 
dairy products were significantly associated with the increased  
seroprevalence.  
¾ Awareness of brucellosis was significantly associated with the 
decreased  seroprevalence. 
¾ Gender and nature of work among the animal handlers did not show 
any significant association. 
¾ The results of this study emphasizes that contact with animals and  
ingestion of contaminated animal products are important methods of 
transmission of brucellosis. 
¾ To prevent the occupation related brucellosis the veterinary health 
professionals, animal  husbandary workers and laboratory personnel 
should wear PPE and follow adequate hand hygienic measures. 
¾ There is no human vaccine to prevent brucellosis in man. Since the 
disease has been seen as a major occupational hazard to the animal 
handlers, the successful way for the  control of disease  in human 
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beings is  by  proper elimination of the infected animals and 
vaccinating the non infected animals. 
¾ Reporting the existence of brucellosis to health authorities and 
veterinary professionals is essential and knowledge about the 
prevalence of the disease can be used to prioritize a disease control 
strategy and to alert the health authorities.  
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Annexure-I 
DATA SHEET FOR COLLECTION OF SOCIO-DEMOGRAPHIC PROFILE  
FOR P.G DISSERTATION WORK ON 
“Seroprevalence of brucellosis among animal handlers and 
analysis of risk  factors” 
 
1. General information 
 Name        :                                          Age:                              Sex: M / F 
Address   :                                             Occupation: 
Residential Background  :   Urban / Semi urban /    Rural                                                    
Socio Economic Status   :          Upper/ Middle/ Low. 
Educational Status         :          Illiterate/ Elementary/Higher secon /Graduate 
 H/o handling animals    :          Yes / No 
 H/o consumption of        :         Raw milk/raw dairy products 
2. Occupational History 
 i. Occupation  : Animal Keeper/ Veterinarian/Livestock  
     Inspector Butchers/ Abattoir Worker/   
     Vet.Hospital Worker Meat Seller/ Milk  
     handlers/ Others.    
 
ii. Type of animal handling  : Cattle/ Sheep/Pet animals/ others 
iii. Duration of contact with animal  : 
iv. H/o handling animal product : Yes/No 
iv. H/o handling animal blood     : Yes/No 
v.  H/o handling animal vaccine for Brucella : Yes/No 
vi  Awareness of brucellosis :  Yes/No 
3.Lab investigations 
 i.  Sample              :     Blood for serum 
ii. Investigation    :        IgG ELISA for Brucella 
4. Report  
Name      :        Age/ Sex        :   
Address  :              Sample           :   Blood 
                                                                   Received On   : 
                                                                   Reported On    : 
       
                                                                     
Test Method Sample OD Reference OD Value 
 Brucella IgG Indirect ELISA 
(Vircel) 
           < 9   =   Negative 
     9-11 = Equivocal 
     >11  =    Positive 
 
 
Interpretation:      
                                                                                       
                                                                                Signature 
 
 
 
S.No Age Sex Occupation
Duration of 
exposure to 
animals
Handling brucella 
vaccine
Handling of animal 
products
Raw  dairy 
consumption
Awareness IgG ELISA Result
1 45 M Vet.Surgeon 22 No yes No Yes 1.69 Negative
2 51 M Vet.Surgeon 26 No yes No Yes 0.738 Negative
3 46 M Vet.Surgeon 25 No yes No Yes 9.5 Negative
4 45 M Vet.Surgeon 22 Yes yes Yes Yes 22.6 Positive
5 44 M Vet.Surgeon 20 No yes No Yes 1.5 Negative
6 50 M Vet.Surgeon 23 No yes No Yes 2.707 Negative
7 48 M Vet.Surgeon 24 Yes yes No Yes 17.32 Positive
8 46 M Vet.Surgeon 25 No yes No Yes 0.707 Negative
9 46 M Vet.Surgeon 23 No yes No Yes 1.2 Negative
10 48 M Vet.Surgeon 24 No yes Yes Yes 18.8 Positive
11 42 M Vet.Surgeon 20 No yes No Yes 4.183 Negative
12 42 M Vet.Surgeon 20 No yes No Yes 0.81 Negative
13 43 M Vet.Surgeon 20 No yes No Yes 3 Negative
14 29 M Vet.Surgeon 10 No yes No Yes 1.661 Negative
15 45 M Vet.Surgeon 23 No yes No Yes 0.83 Negative
16 45 M Vet.Surgeon 5 No yes No Yes 0.738 Negative
17 51 M Vet.Surgeon 27 Yes yes No Yes 19.5 Positive
18 48 M Vet.Surgeon 25 No yes No Yes 0.692 Negative
19 50 M Vet.Surgeon 23 No yes No Yes 1.107 Negative
20 50 M Vet.Surgeon 27 No yes No Yes 23.4 Positive
21 52 M Vet.Surgeon 29 No yes No Yes 5.07 Negative
22 38 F Vet.Surgeon 14 No yes No Yes 0.923 Negative
23 37 M Vet.Surgeon 15 No yes No Yes 0.8 Negative
24 51 M Vet.Surgeon 30 Yes yes No Yes 29.33 Positive
25 27 F Vet.Surgeon 9 No yes No Yes 4.266 Negative
26 40 F Vet.Surgeon 14 No yes No Yes 0.8 Negative
27 45 M Vet.Surgeon 23 No yes No Yes 0.92 Negative
28 38 F Vet.Surgeon 15 No yes No Yes 1.733 Negative
MASTER CHART
SOCIO‐DEMOGRAPHIC  DATA AND TEST RESULTS
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29 31 M Vet.Surgeon 12 No yes No Yes 1.066 Negative
30 42 M Vet.Surgeon 19 No yes No Yes 1.146 Negative
31 53 M Vet.Surgeon 28 No yes No Yes 5.74 Negative
32 51 M Vet.Surgeon 30 Yes yes Yes Yes 8.82 Negative
33 29 M Vet.Surgeon 10 No yes No Yes 0.81 Negative
34 48 M Vet.Surgeon 23 Yes yes Yes Yes 0.72 Negative
35 27 F Vet.Surgeon 6 No yes No Yes 1.1 Negative
36 32 M Vet.Surgeon 15 No yes Yes Yes 1.09 Negative
37 30 M Vet.Surgeon 10 No yes No Yes 0.92 Negative
38 39 M Vet.Surgeon 15 No yes No Yes 0.97 Negative
39 34 F Vet.Surgeon 12 No yes Yes Yes 0.58 Negative
40 53 M Vet.Surgeon 30 Yes yes No Yes 13.1 Positive
41 32 M Vet.Surgeon 10 No yes No Yes 2.21 Negative
42 43 M Vet.Surgeon 20 Yes yes Yes Yes 22.36 Positive
43 40 M Vet.Surgeon 18 Yes yes No Yes 2.86 Negative
44 42 F Vet.Surgeon 22 No yes No Yes 1.92 Negative
45 57 M Vet.Surgeon 32 Yes yes No Yes 28.36 Positive
46 38 M Vet.Surgeon 19 No yes No Yes 0.84 Negative
47 51 M Vet.Surgeon 25 Yes yes No Yes 16.09 Positive
48 34 M Vet.Surgeon 10 No yes No Yes 0.65 Negative
49 42 F Vet.Surgeon 15 No yes No Yes 8.5 Negative
50 26 F Vet.Surgeon 6 No yes Yes Yes 0.826 Negative
51 42 M Vet.Surgeon 18 Yes yes No Yes 0.9 Negative
52 38 M Vet.Surgeon 14 No yes No Yes 0.85 Negative
53 30 M Vet.Surgeon 8 No yes Yes Yes 1.1 Negative
54 34 F Vet.Surgeon 14 No yes No Yes 0.89 Negative
55 37 F Vet.Surgeon 14 No yes No Yes 0.96 Negative
56 30 F Vet.Surgeon 5 No yes Yes Yes 1.96 Negative
57 38 M Vet.Surgeon 20 No yes Yes Yes 0.826 Negative
58 42 M Vet.Surgeon 8 Yes yes No Yes 1.173 Negative
59 42 M Vet.Surgeon 15 No yes Yes Yes 2.4 Negative
60 40 M Vet.Surgeon 20 No yes No Yes 0.93 Negative
61 42 M Vet.Surgeon 15 Yes yes Yes Yes 3.04 Negative
62 41 M Vet.Surgeon 18 Yes yes No Yes 4.58 Negative
63 43 M Vet.Surgeon 17 No yes No Yes 1.573 Negative
64 37 M Vet.Surgeon 14 No yes Yes Yes 1.13 Negative
65 51 M Vet.Surgeon 26 No yes No Yes 0.973 Negative
66 42 M Vet.Surgeon 30 No yes No Yes 5.06 Negative
67 44 M Vet.Surgeon 12 No yes Yes Yes 0.68 Negative
68 27 M Vet.Surgeon 8 No yes No Yes 0.82 Negative
69 47 M Vet.Surgeon 23 No yes No Yes 3.38 Negative
70 44 M Vet.Surgeon 23 Yes yes Yes Yes 21.81 Positive
71 44 M Vet.Surgeon 22 No yes No Yes 0.6 Negative
72 36 M Vet.Surgeon 11 No yes No Yes 2 Negative
73 45 M Vet.Surgeon 22 No yes No Yes 1.63 Negative
74 53 M Vet.Surgeon 26 No yes No Yes 2.87 Negative
75 47 M Vet.Surgeon 23 No yes No Yes 4.27 Negative
76 43 M Vet.Surgeon 20 No yes Yes Yes 2.17 Negative
77 32 M Vet.Surgeon 13 No yes No Yes 2.914 Negative
78 27 M Vet.Surgeon 8 No yes No Yes 0.6 Negative
79 27 M Vet.Surgeon 8 No yes No Yes 0.82 Negative
80 65 M Farmer 10 No No No Yes 0.6 Negative
81 33 M Farmer 12 No No Yes No 0.51 Negative
82 37 M Farmer 5 No No No No 0.8 Negative
83 47 M Farmer 15 No No No No 0.77 Negative
84 35 M Farmer 20 No No Yes Yes 1.72 Negative
85 42 M Vet.Surgeon 17 No Yes No No 1.13 Negative
86 52 M Vet.Hosp work 27 No Yes Yes No 11.7 Positive
87 58 M Vet.Hosp work 30 No Yes No No 0.75 Negative
88 45 M Vet.Hosp work 15 No Yes No No 3.6 Negative
89 43 M Vet.Hosp work 18 No Yes Yes Yes 2 Negative
90 54 M Vet.Hosp work 24 No Yes No No 4.9 Negative
91 54 M Vet.Hosp work 35 No Yes No No 3.7 Negative
92 47 M Vet.Hosp work 19 No Yes Yes Yes 3.6 Negative
93 54 M Vet.Hosp work 14 No Yes No No 0.6 Negative
94 56 M Vet.Hosp work 30 No Yes No Yes 0.51 Negative
95 43 F Vet.Hosp work 20 No Yes No Yes 0.75 Negative
96 55 M Vet.Hosp work 35 No Yes Yes Yes 1.07 Negative
97 54 M Vet.Hosp work 26 No Yes No Yes o.7 Negative
98 49 M Vet.Hosp work 33 Yes Yes No Yes 5.32 Negative
99 54 M Vet.Hosp work 22 No Yes Yes Yes 0.8 Negative
100 58 M Vet.Hosp work 22 No Yes No No 0.77 Negative
101 57 M Vet.Hosp work 14 No Yes Yes Yes 0.7 Negative
102 50 M Vet.Hosp work 35 No Yes No Yes 0.9 Negative
103 56 F Vet.Hosp work 30 No Yes Yes No 22.5 Positive
104 41 M Vet.Hosp work 11 No Yes No Yes 2.2 Negative
105 53 M Vet.Hosp work 15 No Yes No Yes 1.4 Negative
106 45 M Vet.Hosp work 5 No No No No 0.8 Negative
107 52 M Vet.Hosp work 27 No Yes No Yes 0.9 Negative
108 56 M Vet.Hosp work 20 yes Yes Yes No 15.8 Positive
109 45 M Vet.Hosp work 5 No Yes No No 3.977 Negative
110 40 M Vet.Hosp work 5 No Yes No Yes 1.5 Negative
111 50 M Vet.Hosp work 6 No Yes Yes No 3.76 Negative
112 42 M Vet.Hosp work 12 No Yes No Yes 1.3 Negative
113 52 M Vet.Hosp work 25 No Yes No Yes 1.6 Negative
114 52 M Vet.Hosp work 15 No Yes Yes Yes 1 Negative
115 53 M Vet.Hosp work 27 No Yes No Yes 5.7 Negative
116 57 M Vet.Hosp work 30 No Yes Yes No 11.5 Positive
117 56 M Vet.Hosp work 36 No Yes Yes Yes 5.46 Negative
118 49 M Vet.Hosp work 35 No Yes No No 2.4 Negative
119 45 M Vet.Hosp work 25 No Yes No Yes 0.7 Negative
120 46 M Vet.Hosp work 20 Yes Yes Yes No 14 Positive
121 43 F Vet.Hosp work 5 No No No Yes 1.8 Negative
122 48 M Vet.Hosp work 15 No Yes Yes No 1.4 Negative
123 43 M Vet.Hosp work 12 No Yes No Yes 0.5 Negative
124 53 M Vet.Hosp work 13 No Yes No No 1.08 Negative
125 53 M Vet.Hosp work 27 No Yes No Yes 3.4 Negative
126 54 M Vet.Hosp work 28 No Yes Yes Yes 1.05 Negative
127 50 M Vet.Hosp work 30 No Yes Yes No 21.4 Positive
128 44 M Vet.Hosp work 12 Yes Yes Yes No 17 Positive
129 55 M Vet.Hosp work 24 Yes Yes No No 26.3 Positive
130 51 M Vet.Hosp work 20 No Yes No Yes 6.11 Negative
Abbreviations M ‐ Male, F ‐ Female Vet.Hosp work ‐ Veterinary Hospital worker
Vet.Surgeon ‐ Veterinary Surgeon
S.No Age Sex Occupation
Handling of 
animals
Duration of exposure 
to animals
Handling brucella 
vaccine
Raw  dairy Awareness IgG ELISA Result
1 35 M Doctors No Nil Nil No Yes 1.69 Negative
2 37 M Doctors No Nil Nil No Yes 0.738 Negative
3 39 M Doctors No Nil Nil No Yes 1.32 Negative
4 41 M Doctors No Nil Nil No Yes 0.8 Negative
5 36 F Doctors No Nil Nil No Yes 1.5 Negative
6 37 M Doctors No Nil Nil No Yes 2.707 Negative
7 36 M Doctors No Nil Nil Yes Yes 1.5 Negative
8 35 M Doctors No Nil Nil No Yes 0.707 Negative
9 35 F Doctors No Nil Nil No Yes 3.6 Negative
10 38 M Doctors No Nil Nil No Yes 1.2 Negative
11 39 M Doctors No Nil Nil No Yes 4.183 Negative
12 41 M Doctors No Nil Nil No Yes 0.81 Negative
13 40 M Doctors No Nil Nil No Yes 2.5 Negative
14 35 F Doctors No Nil Nil No Yes 1.78 Negative
15 36 M Doctors No Nil Nil Yes Yes 0.752 Negative
16 38 M Doctors No Nil Nil No Yes 0.869 Negative
17 38 M Doctors No Nil Nil No Yes 0.56 Negative
18 38 F Doctors No Nil Nil No Yes 0.34 Negative
19 53 M Doctors No Nil Nil No Yes 1.27 Negative
20 47 M Doctors No Nil Nil No Yes 4.23 Negative
21 52 M Doctors No Nil Nil No Yes 4.96 Negative
22 37 F Doctors No Nil Nil No Yes 0.759 Negative
23 37 M Doctors No Nil Nil No Yes 0.82 Negative
24 56 M Doctors No Nil Nil Yes Yes 3.56 Negative
25 36 F Doctors No Nil Nil No Yes 4.12 Negative
26 39 F Doctors No Nil Nil No Yes 0.8 Negative
27 42 M Doctors No Nil Nil No Yes 0.96 Negative
28 49 F Doctors No Nil Nil No Yes 1.23 Negative
29 45 M Doctors No Nil Nil No Yes 1.012 Negative
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30 46 F Doctors No Nil Nil No Yes 1.06 Negative
31 44 M Doctors No Nil Nil No Yes 4.01 Negative
32 48 M Doctors No Nil Nil No Yes 3.65 Negative
33 45 F Doctors No Nil Nil No Yes 0.81 Negative
34 49 M Doctors No Nil Nil No Yes 0.75 Negative
35 34 F Students No Nil Nil No Yes 1.023 Negative
36 26 F Students No Nil Nil Yes Yes 1.09 Negative
37 32 F Students No Nil Nil No Yes 0.756 Negative
38 27 F Students No Nil Nil No Yes 0.845 Negative
39 31 F Students No Nil Nil No Yes 0.562 Negative
40 36 M Students No Nil Nil No Yes 4.36 Negative
41 30 F Students No Nil Nil No Yes 2.65 Negative
42 25 F Students No Nil Nil No Yes 1.95 Negative
43 37 F Students No Nil Nil No Yes 1.65 Negative
44 40 F Students No Nil Nil No Yes 1.32 Negative
45 37 M Students No Nil Nil No Yes 1.96 Negative
46 27 F Students No Nil Nil No Yes 0.84 Negative
47 35 F Students No Nil Nil No Yes 2.15 Negative
48 38 F Students No Nil Nil No Yes 0.692 Negative
49 42 F Students No Nil Nil No Yes 0.98 Negative
50 29 F Students No Nil Nil No Yes 0.826 Negative
51 33 M Students No Nil Nil No Yes 1.2 Negative
52 32 F Students No Nil Nil No Yes 1.65 Negative
53 28 F Students No Nil Nil No Yes 1.2 Negative
54 33 M Students No Nil Nil No Yes 0.96 Negative
55 26 M Students No Nil Nil No Yes 0.925 Negative
56 25 F Students No Nil Nil No Yes 1.45 Negative
57 28 F Students No Nil Nil Yes Yes 0.85 Negative
58 32 F Students No Nil Nil No Yes 1.026 Negative
59 28 M Students No Nil Nil No Yes 1.89 Negative
60 28 F Students No Nil Nil No Yes 0.963 Negative
61 31 F Students No Nil Nil No Yes 3.04 Negative
62 29 F Students No Nil Nil No Yes 3.65 Negative
63 29 M Students No Nil Nil No Yes 1.256 Negative
64 28 F Students No Nil Nil No Yes 1.09 Negative
65 29 F Students No Nil Nil No Yes 2.61 Negative
66 30 M Students No Nil Nil No Yes 3.65 Negative
67 26 F Students No Nil Nil No Yes 0.965 Negative
68 28 F Students No Nil Nil No Yes 1.86 Negative
69 31 F Students No Nil Nil No Yes 1.396 Negative
70 32 M Students No Nil Nil Yes Yes 2.95 Negative
71 34 F Students No Nil Nil No Yes 3.2 Negative
72 27 F Students No Nil Nil No Yes 1.956 Negative
73 28 F Students No Nil Nil No Yes 1.65 Negative
74 27 F Students No Nil Nil No Yes 2.65 Negative
75 31 M Students No Nil Nil No Yes 3.86 Negative
76 26 F Students No Nil Nil No Yes 2.56 Negative
77 39 M Lab tehnicians No Nil Nil No Yes 2.69 Negative
78 35 M Lab tehnicians No Nil Nil No Yes 0.768 Negative
79 42 M Lab tehnicians No Nil Nil No Yes 0.82 Negative
80 27 M Lab tehnicians No Nil Nil No Yes 0.6 Negative
81 31 M Lab tehnicians No Nil Nil No No 0.59 Negative
82 32 F Lab tehnicians No Nil Nil No No 0.81 Negative
83 29 M Lab tehnicians No Nil Nil No No 0.82 Negative
84 31 M Lab tehnicians No Nil Nil No No 1.68 Negative
85 29 F Lab tehnicians No Nil Nil No No 1.69 Negative
86 32 M Lab tehnicians No Nil Nil No No 1.25 Negative
87 31 F Lab tehnicians No Nil Nil No No 0.862 Negative
88 29 M Lab tehnicians No Nil Nil No No 3.56 Negative
89 28 M Lab tehnicians No Nil Nil Yes Yes 2 Negative
90 42 F Lab tehnicians No Nil Nil No No 1.32 Negative
91 37 M Lab tehnicians No Nil Nil No No 3.36 Negative
92 38 F Lab tehnicians No Nil Nil Yes No 2.5 Negative
93 35 M Lab tehnicians No Nil Nil No No 1.01 Negative
94 41 M Lab tehnicians No Nil Nil No No 0.86 Negative
95 29 F Lab tehnicians No Nil Nil No No 0.12 Negative
96 38 M Lab tehnicians No Nil Nil No No 2.01 Negative
97 37 M Lab tehnicians No Nil Nil No No 1.07 Negative
98 50 F Clerical staffs No Nil Nil No No 4.32 Negative
99 46 M Clerical staffs No Nil Nil No No 0.8 Negative
100 37 M Clerical staffs No Nil Nil No No 0.96 Negative
101 29 M Clerical staffs No Nil Nil No No 0.845 Negative
102 48 M Clerical staffs No Nil Nil No No 0.925 Negative
103 46 F Clerical staffs No Nil Nil No No 4.2 Negative
104 25 M Clerical staffs No Nil Nil No No 2.65 Negative
105 27 M Clerical staffs No Nil Nil No No 1.98 Negative
106 47 F Clerical staffs No Nil Nil No No 2.65 Negative
107 39 M Clerical staffs No Nil Nil No No 3.6 Negative
108 38 M Clerical staffs No Nil Nil No No 1.65 Negative
109 42 M Clerical staffs No Nil Nil No No 3.654 Negative
110 32 F Clerical staffs No Nil Nil No Yes 1.12 Negative
111 28 M Clerical staffs No Nil Nil No No 3.48 Negative
112 26 M Clerical staffs No Nil Nil No No 1.65 Negative
113 33 F Clerical staffs No Nil Nil No No 1.6 Negative
114 34 M Clerical staffs No Nil Nil Yes No 1 Negative
115 34 F Clerical staffs No Nil Nil No No 2.5 Negative
116 34 F Clerical staffs No Nil Nil No No 2.65 Negative
117 32 M Clerical staffs No Nil Nil No No 2.45 Negative
118 35 M Clerical staffs No Nil Nil No No 3.254 Negative
119 31 F Clerical staffs No Nil Nil No No 0.845 Negative
120 37 M Clerical staffs No Nil Nil No No 4.1 Negative
121 37 F Clerical staffs No Nil Nil No No 2.96 Negative
122 45 M Clerical staffs No Nil Nil No No 1.52 Negative
123 48 M Clerical staffs No Nil Nil No Yes 0.658 Negative
124 39 F Clerical staffs No Nil Nil No No 1.64 Negative
125 47 M Clerical staffs No Nil Nil No No 3.584 Negative
126 56 M Clerical staffs No Nil Nil No No 2.54 Negative
127 45 M Clerical staffs No Nil Nil Yes No 1.365 Negative
128 49 M Clerical staffs No Nil Nil No No 1.346 Negative
129 37 F Clerical staffs No Nil Nil No No 1.355 Negative
130 50 M Clerical staffs No Nil Nil No No 3.265 Negative
Abbreviations M ‐ Male, F ‐ Female
